CVI-LM-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCVI-LM-001
Drug Alias NameCVI-LM-001CVI-LM001C-8304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXiwei'Ai Medicine Technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXiwei'Ai Medicine Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A